believe study of bimagrumab + semaglutide American Diabetes Association Weight loss and better health

This landscape has been shifting and is best treated as genuinely in flux rather than settled

On average weight loss, Mounjaro generally outperforms Wegovy in trials (around 20% vs 12 to 15%)

Highly recommended during pregnancy for high-risk women, those with insufficient oral intake, or absorption issues

Patients who relied heavily on the injections without making meaningful changes to their diet and exercise routine are at higher risk for weight regain

At the end of the trial, 37 percent of people in the Wegovy group had less scar tissue in their liver than they did when the trial began, versus 22 percent of those on placebo